Thrombosis in otherwise well children with the factor V Leiden mutation (Q43430509)

23 November 2017

title

Thrombosis in otherwise well children with the factor V Leiden mutation (English)

1 reference

23 November 2017

1 reference

1 reference

Sifontes MT

1

1 reference

23 November 2017

Nuss R

2

1 reference

23 November 2017

Jacobson LJ

3

1 reference

23 November 2017

Griffin JH

4

1 reference

23 November 2017

Manco-Johnson MJ

5

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

The Journal of Pediatrics

23 November 2017

published in

1 reference

23 November 2017

volume

128

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

324-328

1 reference

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Resistance to activated protein C as a basis for venous thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Severe neonatal protein C deficiency: Prevalence and thrombotic risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Improved management of the Paget-Schroetter syndrome secondary to thoracic outlet compression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Treatment of Paget-Schroetter syndrome. A staged, multidisciplinary approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Conventional versus thrombolytic therapy in spontaneous (effort) axillary-subclavian vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Mutation in blood coagulation factor V associated with resistance to activated protein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Activated protein C resistance caused by Arg506Gln mutation in factor Va

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Resistance to activated protein C as an underlying cause of recurrent venous thrombosis during relapsing nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

Characterization of the molecular defect in factor VR506Q

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970275-5

10.1016/S0022-3476(96)70275-5

7 January 2021

Identifiers

DOI

1 reference

23 November 2017

1 reference